Novateor Research Laboratories Ltd - 542771 - Board Meeting Intimation for Appointment Of Statutory Auditor
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2020 ,inter alia, to consider and approve 1. To appoint new Statutory Auditor to fill causal vacancy due to resignation of existing Statutory Auditor of the Company. 2. To transact any other matter with prior approval of chairman. Novateor Research Laboratories Ltd - 542771 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Navdeep MehtaDesignation :- Managing Director / Whole Time Director Novateor Research Laboratories Ltd - 542771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 30th June, 2020 Novateor Research Laboratories Ltd - 542771 - Disclosure Of Material Impact Of COVID-19 Pandemic On The Company Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure of material impact of COVID-19 pandemic on the Company with reference to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020 and read with Regulation 30 of SEBI (LODR) Regulations, 2015. Novateor Research Laboratories Ltd - 542771 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNovateor Research Laboratories Ltd 2CINU24230GJ2011PLC064731 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Poonam Pravinbhai Panchal Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Navdeep Mehta Designation: Chief Financial Officer EmailId: [email protected] Date: 21/05/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Novateor Research Laboratories Ltd - 542771 - Compliance Certificate From PCS Under Reg. 40(9) From PCS For Half Year Ended On March 31, 2020
The compliance certificate by Practicing Company Secretary for the half year ended on 31st March, 2020 pursunt to Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 Novateor Research Laboratories Ltd - 542771 - Shareholding for the Period Ended March 31, 2020
Novateor Research Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here Novateor Research Laboratories Ltd - 542771 - Compliance Certificate In The Matter Of Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirement) Regulations 2015 For The Half Year Ended On 31St March, 2020
Herewith enclosed the compliance certificate for the half year ended on 31st March, 2020 pursuant to Regulation 7(3) of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, Novateor Research Laboratories Ltd - 542771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are enclosed herewith the confirmation certificate dated 3rd April, 2020 received from our Registrar and Transfer Agent (RTA) i.e. KFin Technologies Private Limited for the Quarter ended 31st March, 2020. Novateor Research Laboratories Ltd - 542771 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Navdeep MehtaDesignation :- Managing Director / Whole Time Director